Bringing the fundamentals into focus…
Back to Corvus Pharmaceuticals, Inc.
How Corvus Pharmaceuticals, Inc. stacks up
CRVS · against 486 other Healthcare companies of similar size
Profitability
22/ 100
Near the bottom of its peers.
Ranked #395 of 487 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score50 peers with a profitability score of 20–29, including CRVS · Click a bar to see the companies
Why profitability scores 22?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 82% of peers. Return on assets: -22.6% vs peer median 1.7%
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -21.8% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = CRVS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRVS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 460 reported | -21.8% | 3.7% | 18% | 33% | |
| Operating marginHigher is better · 455 reported | Not reported | 5.6% | — | — | 33% |
| Return on assetsHigher is better · 480 reported | -22.6% | 1.4% | 15% | 33% | |
| Return on equityHigher is better · 459 reported | -35.4% | 2.1% | 18% | Context only | |
| Gross marginHigher is better · 505 reported | 0.0% | 44.0% | 2% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CRVS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 389 | 471M USD | 23 | 21 | |
| 389 | 469M USD | 23 | 50 | |
| 389 | 57.0B INR (≈$684M) | 23 | 40 | |
| 389 | 595M USD | 23 | 29 | |
| 395 | 827M USD | 22 | 41 | |
| 395 | 1.6B USD | 22 | 30 | |
| 395 | 1.1B USD | 22 | 46 | |
| 398 | 6.8B CNY (≈$947M) | 21 | 27 | |
| 398 | 560M USD | 21 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score